COMMUNIQUÉS West-GlobeNewswire
-
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
12/11/2025 -
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
12/11/2025 -
Ascendis Pharma Reports Third Quarter 2025 Financial Results
12/11/2025 -
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
12/11/2025 -
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
12/11/2025 -
dacadoo Celebrates 15 Years of Innovation in Digital Health Engagement
12/11/2025 -
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
12/11/2025 -
Ageless Innovation Launches the Purple Play Packs to Support Alzheimer’s Association
12/11/2025 -
ARC Fertility Highlights Landmark Global Studies Published in The Lancet Calling for National Action on Endometriosis
12/11/2025 -
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
12/11/2025 -
Cortland Biomedical Announces Leadership Updates to Support Next Phase of Growth
12/11/2025 -
Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy
12/11/2025 -
Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
12/11/2025 -
All Better Pediatrics is Now Part of Zarminali Pediatrics, Bringing Future of Care to Tennessee Families
12/11/2025 -
Eleos Secures Landmark ISO/IEC 42001:2023 Certification, the First Global Standard for AI Systems Development and Security
12/11/2025 -
Aeroflow Health and AlohaCare Partner to Expand Access to DME in Hawaii
12/11/2025 -
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
12/11/2025 -
Mochi Health Expands Beyond Obesity Care with Comprehensive Digital Health Platform, Adding 15 New Categories of Care
12/11/2025 -
Marius Pharmaceuticals Expands Global Footprint with Health Canada Approval of KYZATREX® (testosterone undecanoate) CIII Capsules
12/11/2025
Pages